Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamad Reza Davarpanah"'
Autor:
Samieh Asadian, Abbas Piryaei, Nematollah Gheibi, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Mehdi Azad, Valentina Kapustina, Mehdi Alikhani, Sahar Moghbeli Nejad, Hani Keshavarz Alikhani, Morteza Mohamadi, Anastasia Shpichka, Peter Timashev, Moustapha Hassan, Massoud Vosough
Publikováno v:
Cells, Vol 13, Iss 17, p 1456 (2024)
In the original publication [...]
Externí odkaz:
https://doaj.org/article/b31f0d9532c94ede97995fc7d838f2ae
Autor:
Samieh Asadian, Abbas Piryaei, Zahra Farzaneh, Bagher Aziz Kalantari, Mehdi Azad, Sahar Moghbeli Nejad, Mohamad Reza Davarpanah, Morteza Mohamadi, Anastasia Shpichka, Nematolah Gheibi, Peter Timashev, Massoud Vosough
Publikováno v:
Cell Journal, Vol 24, Iss 5, Pp 215-221 (2022)
Objectives: Epigenetic alterations, including any change in DNA methylation pattern, could be the missing link of understanding radiation-induced genomic instability. Dapper, Dishevelled-associated antagonist of β-catenin homolog 2 (DACT2) is a tumo
Externí odkaz:
https://doaj.org/article/a4991207688d419e90c4eaef44da939a
Rhenium Perrhenate (188ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells
Autor:
Samieh Asadian, Abbas Piryaei, Nematollah Gheibi, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Mehdi Azad, Valentina Kapustina, Mehdi Alikhani, Sahar Moghbeli Nejad, Hani Keshavarz Alikhani, Morteza Mohamadi, Anastasia Shpichka, Peter Timashev, Moustapha Hassan, Massoud Vosough
Publikováno v:
Cells, Vol 11, Iss 2, p 305 (2022)
Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a crucial challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy can pote
Externí odkaz:
https://doaj.org/article/e9b82dfb835145258afdd5c9f54e7310
Autor:
Nematolah Gheibi, Anastasia Shpichka, Samieh Asadian, Mehdi Azad, Mohamad Reza Davarpanah, Valentina Kapustina, Morteza Mohamadi, Massoud Vosough, Samaneh Saberi, Abbas Piryaei, Peter S. Timashev, Bagher Aziz Kalantari, Moustapha Hassan, Sahar Moghbeli Nejad
Background Recurrence in hepatocellular carcinoma (HCC) after conventional treatments is a big challenge. Despite the promising progress in advanced targeted therapies, HCC is the fourth leading cause of cancer death worldwide. Radionuclide therapy c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c81d604ae3daadf4e5da10aa28b6eab4
https://doi.org/10.21203/rs.3.rs-398524/v1
https://doi.org/10.21203/rs.3.rs-398524/v1
Autor:
Peter S. Timashev, Leila Nasehi, Nematollah Gheibi, Morteza Mohamadi, Anastasia Shpichka, Mohamad Reza Davarpanah, Moustapha Hassan, Bagher Aziz Kalantari, Samieh Asadian, Massoud Vosough, Hamidreza Aboulkheyr Es, Hamed Mirzaei, Mustapha Najimi
Publikováno v:
Pharmacological research. 160
Targeted radionuclide therapy, known as molecular radiotherapy is a novel therapeutic module in cancer medicine. β-radiating radionuclides have definite impact on target cells via interference in cell cycle and particular signalings that can lead to